Back to Search
Start Over
Publisher Correction: ERK1/2 phosphorylation predicts survival following anti-PD-1 immunotherapy in recurrent glioblastoma.
- Source :
-
Nature cancer [Nat Cancer] 2022 Mar; Vol. 3 (3), pp. 373. - Publication Year :
- 2022
Details
- Language :
- English
- ISSN :
- 2662-1347
- Volume :
- 3
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Nature cancer
- Accession number :
- 35149861
- Full Text :
- https://doi.org/10.1038/s43018-022-00343-8